{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:47:33Z","timestamp":1792075653983,"version":"4.4.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Xing Dian Talent Support Program","award":["2023MY007"],"award-info":[{"award-number":["2023MY007"]}]},{"name":"Xing Dian Talent Support Program","award":["2023MY007"],"award-info":[{"award-number":["2023MY007"]}]},{"name":"Xing Dian Talent Support Program","award":["2023MY007"],"award-info":[{"award-number":["2023MY007"]}]},{"name":"Xing Dian Talent Support Program","award":["2023MY007"],"award-info":[{"award-number":["2023MY007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12945-x","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:30:39Z","timestamp":1792074639000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SERPINB5 promotes pancreatic adenocarcinoma progression through FBXO32-mediated regulation of epithelial-mesenchymal transition"],"prefix":"10.1007","volume":"53","author":[{"given":"Hang","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin-Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"issue":"5","key":"12945_CR1","doi-asserted-by":"publisher","first-page":"438","DOI":"10.21147\/j.issn.1000-9604.2023.05.03","volume":"35","author":"W Luo","year":"2023","unstructured":"Luo W et al (2023) Epidemiology of pancreatic cancer: New version, new vision. Chin J Cancer Res 35(5):438\u2013450","journal-title":"Chin J Cancer Res"},{"issue":"1","key":"12945_CR2","doi-asserted-by":"publisher","first-page":"27769","DOI":"10.1038\/s41598-024-79619-1","volume":"14","author":"Y Li","year":"2024","unstructured":"Li Y et al (2024) Pathomic and bioinformatics analysis of clinical-pathological and genomic factors for pancreatic cancer prognosis. Sci Rep 14(1):27769","journal-title":"Sci Rep"},{"key":"12945_CR3","doi-asserted-by":"crossref","unstructured":"Grigorescu RR, Husar-Sburlan IA, Gheorghe C (2024) Pancreatic Cancer: Rev Risk Factors Life (Basel) 14(8):980","DOI":"10.3390\/life14080980"},{"issue":"19","key":"12945_CR4","doi-asserted-by":"publisher","first-page":"10219","DOI":"10.3390\/ijms221910219","volume":"22","author":"S Hafezi","year":"2021","unstructured":"Hafezi S, Saber-Ayad M, Abdel-Rahman WM (2021) Highlights on the role of KRAS mutations in reshaping the microenvironment of pancreatic adenocarcinoma. Int J Mol Sci 22(19):10219","journal-title":"Int J Mol Sci"},{"issue":"1","key":"12945_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s13402-022-00741-1","volume":"46","author":"Y-H Zhu","year":"2023","unstructured":"Zhu Y-H et al (2023) Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment. Cell Oncol 46(1):17\u201348","journal-title":"Cell Oncol"},{"issue":"6","key":"12945_CR6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/CEJ.0000000000000942","volume":"34","author":"Q Wang","year":"2025","unstructured":"Wang Q, Liu J, Yang Z (2025) Global, regional, and national burden of pancreatic cancer from 1990 to 2021, with projections for 25 years: a systematic analysis for the Global Burden of Disease Study 2021. Eur J Cancer Prev 34(6):493\u2013503","journal-title":"Eur J Cancer Prev"},{"issue":"3","key":"12945_CR7","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"12945_CR8","doi-asserted-by":"crossref","unstructured":"Peng C, Oberstein PE (2025) Emerging Therapeutic Approaches to Pancreatic Adenocarcinoma: Advances and Future Directions. Current Treatment Options in Oncology 1\u201325","DOI":"10.1007\/s11864-025-01352-2"},{"key":"12945_CR9","volume-title":"Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future","author":"A Mannucci","year":"2025","unstructured":"Mannucci A, Goel A (2025) Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future. A Cancer Journal for Clinicians, CA"},{"issue":"1","key":"12945_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1479-7364-7-22","volume":"7","author":"C Heit","year":"2013","unstructured":"Heit C et al (2013) Update of the human and mouse SERPIN gene superfamily. Hum Genomics 7(1):22","journal-title":"Hum Genomics"},{"key":"12945_CR11","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.semcdb.2016.09.005","volume":"62","author":"Y Sun","year":"2017","unstructured":"Sun Y, Sheshadri N, Zong WX (2017) SERPINB3 and B4: From biochemistry to biology. Semin Cell Dev Biol 62:170\u2013177","journal-title":"Semin Cell Dev Biol"},{"issue":"7","key":"12945_CR12","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1158\/0008-5472.CAN-19-2578","volume":"80","author":"C Tian","year":"2020","unstructured":"Tian C et al (2020) Cancer Cell-Derived Matrisome Proteins Promote Metastasis in Pancreatic Ductal Adenocarcinoma. Cancer Res 80(7):1461\u20131474","journal-title":"Cancer Res"},{"key":"12945_CR13","doi-asserted-by":"crossref","unstructured":"Bose S et al (2025) From enzyme to predictors: Serine proteases in cancer diagnosis and prognosis, in Pathophysiological Aspects of Proteases in Cancer. Elsevier, pp 223\u2013237","DOI":"10.1016\/B978-0-443-30098-1.00014-8"},{"issue":"4","key":"12945_CR14","first-page":"812","volume":"7","author":"N Maass","year":"2001","unstructured":"Maass N et al (2001) Expression of the tumor suppressor gene Maspin in human pancreatic cancers. Clin Cancer Res 7(4):812\u2013817","journal-title":"Clin Cancer Res"},{"key":"12945_CR15","doi-asserted-by":"publisher","first-page":"111759","DOI":"10.1016\/j.intimp.2024.111759","volume":"131","author":"B-X Liu","year":"2024","unstructured":"Liu B-X et al (2024) SERPINB5 promotes colorectal cancer invasion and migration by promoting EMT and angiogenesis via the TNF-\u03b1\/NF-\u03baB pathway. Int Immunopharmacol 131:111759","journal-title":"Int Immunopharmacol"},{"key":"12945_CR16","unstructured":"Lidstr\u00f6m T (2022) Immunosuppressive and metastasis-promoting matrisome proteins in pancreatic cancer: the role of galectin 4 and SERPINB5. Ume\u00e5 University"},{"issue":"1","key":"12945_CR17","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1038\/s41598-018-19834-9","volume":"8","author":"T Nakayama","year":"2018","unstructured":"Nakayama T et al (2018) Assessment of suitable reference genes for RT\u2013qPCR studies in chronic rhinosinusitis. Sci Rep 8(1):1568","journal-title":"Sci Rep"},{"issue":"1","key":"12945_CR18","doi-asserted-by":"publisher","first-page":"12022","DOI":"10.1038\/s41598-021-91521-8","volume":"11","author":"Y Xiang","year":"2021","unstructured":"Xiang Y et al (2021) Comparison of the sensitivity of Western blotting between PVDF and NC membranes. Sci Rep 11(1):12022","journal-title":"Sci Rep"},{"issue":"5","key":"12945_CR19","first-page":"1115","volume":"26","author":"K-F Lei","year":"2011","unstructured":"Lei K-F et al (2011) SerpinB5 interacts with KHDRBS3 and FBXO32 in gastric cancer cells. Oncol Rep 26(5):1115\u20131120","journal-title":"Oncol Rep"},{"issue":"1","key":"12945_CR20","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1186\/s12967-025-07164-0","volume":"23","author":"Q Zhang","year":"2025","unstructured":"Zhang Q et al (2025) Metabolic and immune crosstalk between cancer-associated fibroblasts and pancreatic cancer cells. J Translational Med 23(1):1118","journal-title":"J Translational Med"},{"issue":"7","key":"12945_CR21","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1007\/s00262-021-03110-3","volume":"71","author":"H Wang","year":"2022","unstructured":"Wang H et al (2022) Identification of prognostic genes in the pancreatic adenocarcinoma immune microenvironment by integrated bioinformatics analysis. Cancer Immunol Immunother 71(7):1757\u20131769","journal-title":"Cancer Immunol Immunother"},{"key":"12945_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2022.09.049","volume":"632","author":"J Yang","year":"2022","unstructured":"Yang J et al (2022) COL17A1 facilitates tumor growth and predicts poor prognosis in pancreatic cancer. Biochem Biophys Res Commun 632:1\u20139","journal-title":"Biochem Biophys Res Commun"},{"key":"12945_CR23","doi-asserted-by":"crossref","unstructured":"Liu N et al (2021) High matrix metalloproteinase 28 expression is associated with poor prognosis in pancreatic adenocarcinoma. OncoTargets therapy 14:4391\u20134406","DOI":"10.2147\/OTT.S309576"},{"key":"12945_CR24","doi-asserted-by":"crossref","unstructured":"Jiang Y et al (2025) PUS7 promotes the progression of pancreatic cancer by interacting ANLN to activate MYC pathway. Mol Cell Biochem 480(7):4401\u20134415","DOI":"10.1007\/s11010-025-05267-2"},{"issue":"23","key":"12945_CR25","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1111\/1759-7714.15013","volume":"14","author":"X He","year":"2023","unstructured":"He X et al (2023) SERPINB5 is a prognostic biomarker and promotes proliferation, metastasis and epithelial-mesenchymal transition (EMT) in lung adenocarcinoma. Thorac Cancer 14(23):2275\u20132287","journal-title":"Thorac Cancer"},{"issue":"1","key":"12945_CR26","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s11033-025-10293-w","volume":"52","author":"S Zeng","year":"2025","unstructured":"Zeng S et al (2025) The paradoxical role of SERPINB5 in gastrointestinal cancers: oncogene or tumor suppressor? Mol Biol Rep 52(1):188","journal-title":"Mol Biol Rep"},{"issue":"11","key":"12945_CR27","doi-asserted-by":"publisher","first-page":"103412","DOI":"10.3748\/wjg.v31.i11.103412","volume":"31","author":"Z-S Meng","year":"2025","unstructured":"Meng Z-S et al (2025) Inhibition of the SERPINB5\/HSP90AA1 axis restrains the proliferation and invasion of rectal cancer. World J Gastroenterol 31(11):103412","journal-title":"World J Gastroenterol"},{"issue":"5","key":"12945_CR28","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1089\/dna.2021.0056","volume":"40","author":"B Mahananda","year":"2021","unstructured":"Mahananda B et al (2021) SERPINB5 genetic variants rs2289519 and rs2289521 are significantly associated with gallbladder cancer risk. DNA Cell Biol 40(5):706\u2013712","journal-title":"DNA Cell Biol"},{"issue":"3","key":"12945_CR29","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.21037\/jgo-21-283","volume":"12","author":"T Ji","year":"2021","unstructured":"Ji T et al (2021) PADI1 contributes to EMT in PAAD by activating the ERK1\/2-p38 signaling pathway. J Gastrointest Oncol 12(3):1180","journal-title":"J Gastrointest Oncol"},{"issue":"9","key":"12945_CR30","doi-asserted-by":"publisher","first-page":"4364","DOI":"10.3390\/ijms26094364","volume":"26","author":"S Ghafoor","year":"2025","unstructured":"Ghafoor S et al (2025) Molecular Mechanisms Regulating Epithelial Mesenchymal Transition (EMT) to Promote Cancer Progression. Int J Mol Sci 26(9):4364","journal-title":"Int J Mol Sci"},{"issue":"6","key":"12945_CR31","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.7150\/ijbs.76756","volume":"19","author":"Q Ji","year":"2023","unstructured":"Ji Q et al (2023) PYGL-mediated glucose metabolism reprogramming promotes EMT phenotype and metastasis of pancreatic cancer. Int J Biol Sci 19(6):1894","journal-title":"Int J Biol Sci"},{"key":"12945_CR32","doi-asserted-by":"crossref","unstructured":"He R-Z et al (2023) ADAMTS12 promotes migration and epithelial-mesenchymal transition and predicts poor prognosis for pancreatic cancer, vol 22. Hepatobiliary & Pancreatic Diseases International, pp 169\u2013178. 2","DOI":"10.1016\/j.hbpd.2022.04.005"},{"issue":"3","key":"12945_CR33","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3390\/cells10030653","volume":"10","author":"M Oshi","year":"2021","unstructured":"Oshi M et al (2021) Annexin A1 expression is associated with Epithelial\u2013Mesenchymal Transition (EMT), cell proliferation, prognosis, and drug response in pancreatic cancer. Cells 10(3):653","journal-title":"Cells"},{"key":"12945_CR34","doi-asserted-by":"publisher","first-page":"1596344","DOI":"10.3389\/fimmu.2025.1596344","volume":"16","author":"M Dai","year":"2025","unstructured":"Dai M et al (2025) F-box proteins at the crossroads of ubiquitination and tumor immunity: regulatory networks and immunotherapy strategies. Front Immunol 16:1596344","journal-title":"Front Immunol"},{"issue":"4","key":"12945_CR35","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41419-024-06635-4","volume":"15","author":"J Wu","year":"2024","unstructured":"Wu J et al (2024) FBXO32-mediated degradation of PTEN promotes lung adenocarcinoma progression. Cell Death Dis 15(4):282","journal-title":"Cell Death Dis"},{"issue":"6","key":"12945_CR36","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.21037\/tcr-2024-2426","volume":"14","author":"X-H Rao","year":"2025","unstructured":"Rao X-H et al (2025) FBXO32 promotes gastric cancer progression by regulating NME1. Translational Cancer Res 14(6):3520\u20133531","journal-title":"Translational Cancer Res"},{"issue":"10","key":"12945_CR37","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/mc.23331","volume":"60","author":"H Wang","year":"2021","unstructured":"Wang H et al (2021) Association of genetic variants of FBXO32 and FOXO6 in the FOXO pathway with breast cancer risk. Mol Carcinog 60(10):661\u2013670","journal-title":"Mol Carcinog"},{"issue":"16","key":"12945_CR38","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1158\/0008-5472.CAN-23-3638","volume":"84","author":"D Su","year":"2024","unstructured":"Su D et al (2024) FBXO32 stimulates protein synthesis to drive pancreatic cancer progression and metastasis. Cancer Res 84(16):2607\u20132625","journal-title":"Cancer Res"},{"issue":"23","key":"12945_CR39","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.1038\/onc.2016.479","volume":"36","author":"H Zhou","year":"2017","unstructured":"Zhou H et al (2017) FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation. Oncogene 36(23):3312\u20133321","journal-title":"Oncogene"},{"issue":"3","key":"12945_CR40","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/labinvest.2009.138","volume":"90","author":"JL Chou","year":"2010","unstructured":"Chou JL et al (2010) Promoter hypermethylation of FBXO32, a novel TGF-beta\/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer. Lab Invest 90(3):414\u2013425","journal-title":"Lab Invest"},{"key":"12945_CR41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.18632\/genesandcancer.210","volume":"12","author":"MK Sakharkar","year":"2021","unstructured":"Sakharkar MK et al (2021) Key drug-targeting genes in pancreatic ductal adenocarcinoma. Genes Cancer 12:12\u201324","journal-title":"Genes Cancer"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12945-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12945-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12945-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:30:43Z","timestamp":1792074643000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12945-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12945"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12945-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"assertion":[{"value":"10 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In this dissertation, the author used AI tools to assist in literature retrieval and organization\/diagram production\/code debugging and analysis\/grammar proofreading and format checking, etc. The core ideas, research design, conclusions, and innovations of the dissertation were all completed independently by the author. The author conducted a legal review and reasonable editing of the content, completed with the assistance of this tool, and I assume all legal and academic ethical responsibilities for the content of this dissertation.","order":1,"name":"Ethics","label":"AI Disclosure Statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1719"}}